The real-life management of overactive bladder: Turkish Continence Society multicenter prospective cohort study with short-term outcome

Basit Öğe Kaydı
dc.authoridErdogan, Sarper/0000-0003-2693-9916
dc.authoridZumrutbas, Ali Ersin/0000-0001-5933-402X
dc.authoridTarcan, Tufan/0000-0002-3387-3524
dc.authoridCitgez, Sinharib/0000-0002-3897-2951
dc.authoridAcar, Omer/0000-0002-6094-9264
dc.contributor.authorZümrütbaş, Ali E.
dc.contributor.authorCitgez, Sinharib
dc.contributor.authorAcar, Ömer
dc.contributor.authorİzol, Volkan
dc.contributor.authorUzun, Hakkı
dc.contributor.authorKabay, Şahin
dc.contributor.authorSancak, Eyüp B.
dc.date.accessioned2025-01-27T21:04:03Z
dc.date.available2025-01-27T21:04:03Z
dc.date.issued2019
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractIntroduction Turkish Continence Society aimed to analyze how overactive bladder (OAB) is being managed in routine practice by the urologists in Turkey. Material and methods Fourteen urology departments were randomly selected to represent the whole population in this multicenter study. An online data entry and storage software was created for patient recruitment and data assessment. A survey including demographic data, daily habits, lower urinary tract symptoms, and Turkish-validated OAB-V8 and ICIQ-SF questionnaires were completed by all patients. Second part of the survey, including the questions about clinical evaluation and management of the patient, was completed by the treating physician. Results A total of 507 patients (394 female and 113 male) were included. Behavioral therapy was recommended to 73.2% of female and 81.4% of male patients although bladder diary was requested for 59.5% and 52.7% of the female and male patients, respectively. In the first visit, 86.1% of the female and 89.3% of the male patients were given antimuscarinics (P = .431). Antimuscarinic-related side effects occurred in 94.9% and 88.9% of the female and male patients, respectively (P = .937). However, the rate of medical treatment change due to antimuscarinic-related side effects was only 1.7% in female and 4.8% in male patients at the end of 4 months. Conclusions Behavioral therapy and antimuscarinics were the preferred initial treatment modalities of OAB in concordance with the guidelines. Despite guideline recommendations, bladder diaries were not utilized in half of the patients. Insufficient efficacy appeared to be the main reason for treatment modification.
dc.identifier.doi10.1002/nau.24079
dc.identifier.endpage2177
dc.identifier.issn0733-2467
dc.identifier.issn1520-6777
dc.identifier.issue8
dc.identifier.pmid31338880
dc.identifier.scopus2-s2.0-85073584490
dc.identifier.scopusqualityQ2
dc.identifier.startpage2170
dc.identifier.urihttps://doi.org/10.1002/nau.24079
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27537
dc.identifier.volume38
dc.identifier.wosWOS:000479353100001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofNeurourology and Urodynamics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectmanagement
dc.subjectmulticenter
dc.subjectoveractive bladder
dc.subjectstudy
dc.titleThe real-life management of overactive bladder: Turkish Continence Society multicenter prospective cohort study with short-term outcome
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu